Vir Biotechnology Inc (NASDAQ: VIR) |
|
|
|
Vir Biotechnology Inc 's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
Select the Relationship:
|
|
Select the Category:
|
|
COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
Vir Biotechnology Inc |
3 Q 2024 |
VIR |
490.72 |
-261.97 |
- |
-839.83 |
Amgen Inc |
3 Q 2024 |
AMGN |
32,534.00 |
4,230.00 |
13 % |
-25,730.00 |
Gilead Sciences Inc |
3 Q 2024 |
GILD |
27,136.00 |
3,309.00 |
12.19 % |
337.00 |
Biontech Se |
4 Q 2023 |
BNTX |
4,277.28 |
1,041.94 |
24.36 % |
1,355.42 |
Regeneron Pharmaceuticals Inc |
3 Q 2024 |
REGN |
13,097.30 |
3,991.10 |
30.47 % |
-1,344.60 |
Moderna Inc |
3 Q 2024 |
MRNA |
5,081.00 |
-2,224.00 |
-43.77 % |
-1,306.00 |
Seagen Inc |
3 Q 2023 |
SGEN |
2,300.35 |
-750.23 |
-32.61 % |
60.79 |
Exelixis Inc |
3 Q 2024 |
EXEL |
2,081.60 |
1,066.83 |
51.25 % |
-138.51 |
Valneva Se |
4 Q 2023 |
VALN |
172.16 |
-113.60 |
-65.99 % |
388.29 |
Novavax inc |
3 Q 2024 |
NVAX |
885.19 |
-284.86 |
-32.18 % |
-77.78 |
Innate Pharma Sa |
4 Q 2023 |
IPHA |
69.04 |
-8.48 |
-12.28 % |
153.21 |
Iovance Biotherapeutics inc |
3 Q 2024 |
IOVA |
90.86 |
-410.00 |
-451.25 % |
-163.61 |
Sutro Biopharma Inc |
3 Q 2024 |
STRO |
69.79 |
-122.74 |
-175.85 % |
66.07 |
Sorrento Therapeutics Inc |
2 Q 2023 |
SRNEQ |
51.02 |
-324.52 |
-636.01 % |
6.67 |
Alector Inc |
3 Q 2024 |
ALEC |
133.17 |
-136.49 |
-102.49 % |
-332.30 |
Siga Technologies Inc |
3 Q 2024 |
SIGA |
173.73 |
85.71 |
49.33 % |
28.16 |
Invivyd Inc |
3 Q 2024 |
IVVD |
0.00 |
-225.14 |
- |
-74.95 |
Molecular Partners Ag |
4 Q 2023 |
MOLN |
7.04 |
-61.98 |
-880.7 % |
133.72 |
Assembly Biosciences Inc |
3 Q 2024 |
ASMB |
28.33 |
-40.80 |
-144.05 % |
1.80 |
Elutia Inc |
3 Q 2024 |
ELUT |
23.91 |
-54.42 |
-227.58 % |
8.94 |
Aligos Therapeutics Inc |
3 Q 2024 |
ALGS |
10.74 |
-111.88 |
-1041.97 % |
-153.87 |
Eiger Biopharmaceuticals Inc |
4 Q 2023 |
EIGR |
12.14 |
-33.92 |
-279.34 % |
-6.64 |
Armata Pharmaceuticals Inc |
4 Q 2024 |
ARMP |
4.53 |
-69.05 |
-1524.51 % |
-1.57 |
Abeona Therapeutics Inc |
3 Q 2024 |
ABEO |
3.97 |
-71.03 |
-1791.02 % |
11.01 |
Dyadic International Inc |
3 Q 2024 |
DYAI |
2.35 |
-2,514.05 |
-106915.18 % |
-6.92 |
Eterna Therapeutics Inc |
3 Q 2024 |
ERNA |
0.60 |
-44.93 |
-7513.88 % |
-4.38 |
Imunon Inc |
3 Q 2024 |
IMNN |
0.50 |
-24.23 |
-4845.16 % |
0.50 |
Opthea Limited |
2 Q 2024 |
OPT |
0.12 |
-220.24 |
-176665.73 % |
42.65 |
Immunitybio inc |
3 Q 2024 |
IBRX |
0.56 |
-400.55 |
-71911.49 % |
39.78 |
Mymetics Corporation |
3 Q 2023 |
MYMX |
1.23 |
-0.32 |
-26.35 % |
0.42 |
Ambrx Biopharma Inc |
3 Q 2023 |
AMAM |
8.60 |
-134.11 |
-1559.09 % |
-24.61 |
Altimmune inc |
3 Q 2024 |
ALT |
0.05 |
-103.52 |
-199076.92 % |
-55.38 |
Pharmacyte Biotech Inc |
3 Q 2025 |
PMCB |
0.00 |
-5.66 |
- |
-9.98 |
Hillevax Inc |
3 Q 2024 |
HLVX |
0.00 |
-150.28 |
- |
-42.02 |
Apogee Therapeutics Inc |
3 Q 2024 |
APGE |
0.00 |
-135.77 |
- |
31.87 |
Peak Bio Inc |
3 Q 2024 |
PKBO |
0.00 |
-3.32 |
- |
0.77 |
Calidi Biotherapeutics Inc |
3 Q 2024 |
CLDI |
0.00 |
-40.43 |
- |
0.00 |
Sab Biotherapeutics Inc |
3 Q 2024 |
SABS |
58.72 |
-45.57 |
-77.61 % |
6.75 |
Inovio Pharmaceuticals Inc |
3 Q 2024 |
INO |
14.77 |
-112.88 |
-764.26 % |
2.88 |
Cardiol Therapeutics inc |
4 Q 2023 |
CRDL |
0.00 |
-21.55 |
- |
0.00 |
Vaxart Inc |
3 Q 2024 |
VXRT |
16.76 |
-104.60 |
-624.13 % |
-116.46 |
Scinai Immunotherapeutics Ltd |
4 Q 2023 |
SCNI |
0.00 |
6.50 |
- |
0.00 |
Allovir Inc |
3 Q 2024 |
ALVR |
0.00 |
-100.20 |
- |
20.38 |
Nanoviricides inc |
3 Q 2025 |
NNVC |
0.00 |
-9.45 |
- |
-3.10 |
Pardes Biosciences Inc |
2 Q 2023 |
PRDS |
0.00 |
-76.14 |
- |
81.06 |
Compass Therapeutics Inc |
3 Q 2024 |
CMPX |
0.00 |
-47.76 |
- |
6.94 |
Turnstone Biologics Corp |
3 Q 2024 |
TSBX |
0.00 |
-19.15 |
- |
-14.64 |
Intensity Therapeutics Inc |
1 Q 2024 |
INTS |
0.00 |
-15.42 |
- |
0.78 |
Ampio Pharmaceuticals inc |
4 Q 2023 |
AMPE |
0.05 |
-8.63 |
-17264 % |
-8.56 |
Cullinan Therapeutics Inc |
3 Q 2024 |
CGEM |
0.00 |
-145.49 |
- |
37.24 |
Revolution Medicines Inc |
3 Q 2024 |
RVMD |
29.51 |
-567.06 |
-1921.59 % |
-156.64 |
Innovation Pharmaceuticals Inc |
3 Q 2024 |
CTIX |
0.00 |
-14.76 |
- |
3.95 |
Tradeup Acquisition Corp |
1 Q 2024 |
ESLA |
0.00 |
-4.93 |
- |
2.25 |
In8bio Inc |
2 Q 2024 |
INAB |
0.00 |
-31.96 |
- |
-6.77 |
Abivax Sa |
4 Q 2023 |
ABVX |
0.00 |
-165.47 |
- |
0.00 |
Mosaic Immunoengineering Inc |
3 Q 2024 |
PTSC |
0.00 |
-1.06 |
- |
-0.25 |
Cocrystal Pharma Inc |
2 Q 2024 |
COCP |
2.01 |
-36.26 |
-1800.5 % |
-16.00 |
APROX. MARKET |
3 Q |
SUBTOTAL |
88,869.70 |
3,120.26 |
3.51 % |
-26,966.24 |
|
|